Fantastic to see so many immunologists at the #ECI2024, and the drummers at the opening ceremony were brilliant! Looking forward to a packed programme over the next few days. Our work will be represented on posters by @HannahBollons and @fell_ruby on Wednesday.
🎉 The wait is over, #ECI2024 is officially underway!
Stay tuned for exclusive updates, insights, and highlights from the congress as we work together to shape the future of #immunology🌎🔬
#Dublin#ScientificInnovation
Thank you to the @BloodCancer_Res team for visiting @unibirmingham@ImmunologyUoB@IcgsUob this week. It was a real pleasure to meet you, to discuss our Blood Cancer UK funded work, and discuss how we can all work together to fight blood cancer.
We've had a great day @unibirmingham meeting blood cancer researchers, hearing about the exciting progress being made in @bloodcancer_uk funded research and discussing how we can work together to develop kinder, more effective treatments for blood cancer patients
Researchers at @unibirmingham have uncovered a potential link between the #EpsteinBarr virus and #MultipleSclerosis (MS). 20 years of mounting evidence now shows a link between the two, where the virus may trigger MS via brain cross-reactivity.
➡️https://t.co/U74fq2Jgtv
Fantastic two days at @BSI_immunomet in Newcastle, with so many interesting talks and discussions! Also very proud to receive a prize for my poster presentation! #UKImmunoMet24
Wishing all the amazing #WomenInImmunology a great #InternationalWomensDay!
We want to celebrate women's contributions to #immunology by shining a spotlight on the diverse & inspiring careers of some of our #BSIcommittee members 🤩
Read their profiles 👉https://t.co/eaqTBLPj7N
Fantastic to work with @Edgar_lab_UK, @HanJackson22 and collaborators on this excellent study published in #JEV@ISEV_Journals https://t.co/hGFlpKl2WZ, demonstrating the ability of bioengineered exosomes to deliver multiple antigens and stimulate potent immune responses.
Bioengineered small extracellular vesicles can co-administer antigenic fragments – published in #JEV@ISEV_Journals
https://t.co/BN3BMJ1rIQ
Huge congratulations to @HanJackson22 for driving this project. Thanks to colleagues including @LongLabGroup, @Thav_Lab
Overview below;
Sad to hear of the passing of Prof Sir Tony Epstein, discoverer the first human tumour virus, EBV, which is the focus of my group. Such a privilege to meet him and hear him speak at the 50th anniversary of the discovery of EBV in 2014. What an inspiration. https://t.co/Ri1a5pxeKH
Wanting a New Year activity? Our fantastic new CPD course on Immune Checkpoint Blockade Therapy, led by @ProfBenW and Dr Fiyaz Mohammed, is starting on 24th January. Follow the links for further information. @ImmunologyUoB, @unibirmingham, @britsocimm.
Want to get up to speed with immune checkpoint blockade therapy for cancer ?
Register now for this online 13-hour CPD course ‘Understanding immune checkpoint blockade therapy: a pillar of modern cancer treatment’, from the University of Birmingham, UK, starting on Jan 24th, 2024.
🚨We are delighted to announce that recruitment for 2024 studentships is now open!
Projects are across the 3 partner institutions @unibirmingham@uniofleicester and @UniofNottingham Application forms and information are available on the AIM website https://t.co/OHR5xGJmZ7 🧵
Great to be part of this important study investigating immunological risk factors for childhood cancer in cardiac transplant patients. @ITHACA_Study@Docoff3@sbomken
Well done to our PhD students @fell_ruby and @HannahBollons for excellent talks at the @ImmunologyUoB Post Graduate Research Gala this week. A great event showcasing all the exciting work ongoing in the Institute.